Mad Money host Jim Cramer describes the difficult nature of the stock market.
Mad Money host Jim Cramer reacts to terrible news a Malaysia Airlines passenger jet was shot down in Ukraine.
Mad Money host Jim Cramer practices smart speculation and focuses on Fiesta Restaurant Group.
Mad Money host Jim Cramer outlines some of the best ideas from the Delivering Alpha Conference.
Mad Money host Jim Cramer dissects positive gains in the market and takeaways to find the next winners.
With the help of technician Tim Collins, Mad Money host Jim Cramer goes off the charts on Amazon and Netflix.
Mad Money host Jim Cramer explains why he does not like when Fed chiefs address the stock market with gratuitous throwaway comments.
Mad Money host Jim Cramer explains how low expectations provide a margin of safety that can produce spectacular gains after earnings.
Mad Money host Jim Cramer breaks form and explains why piggybacking Nelson Peltz is the one exception to the rule.
Mad Money host Jim Cramer takes a looks at the excuses offered by 4 retail CEOs after delivering poor earnings results and rates the credibility of each "alibi."
Mad Money host Jim Cramer shares examples of how poorly the market has been valuing stocks.
Mad Money host Jim Cramer dissects Macau's move and shares his take on how to profit from gambling stocks.
Mad Money host Jim Cramer explains why it could be a terrific time to gain exposure to major tobacco companies like Altria, Reynolds American and Lorillard.
Mad Money host Jim Cramer looks ahead to market moving earnings and events set to take place next week, including quarterly reports by JPMorgan, Yahoo, and Intel.
In light of heavy M&A action, Mad Money host Jim Cramer looks for the next play in the food and beverage space.
Mad Money host Jim Cramer explains why he thinks Dean Foods is an underappreciated value stock.
Mad Money host Jim Cramer explains why negative news in Europe is a reason to buy not dump American stocks.
David Pyott, Allergan chairman and CEO, discusses its restructuring efforts to unlock value for investors and questions the sustainability of Valeant's business model.
Mad Money host Jim Cramer goes off the charts on biotech's biggest names, Biogen, Regeneron, Gilead and Celgene.
How to bargain hunt successfully? Mad Money host Jim Cramer looks at the best performers from last quarter.